Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura D'Erasmo

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Frontiers in Cardiovascular Medicine|June 13, 2025
Editorial: Cardiovascular risk and lipoprotein(a): beyond LDL cholesterolGiuseppe Mandraffino, Laura D'Erasmo
Current Opinion in Lipidology|February 6, 2020
Familial combined hypolipidemia: angiopoietin-like protein-3 deficiencyMarcello Arca, Laura D'Erasmo, Ilenia Minicocci
Current Atherosclerosis Reports|September 1, 2021
Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)Laura D'Erasmo, Simone Bini, Marcello Arca
Current Opinion in Endocrinology, Diabetes, and Obesity|November 10, 2025
Lessons from recent clinical trials for the prevention of acute pancreatitis in chylomicronemia syndromesLaura D'Erasmo, Daniele Tramontano, Marcello Arca
Current Opinion in Lipidology|February 4, 2020
Autosomal recessive hypercholesterolemia: update for 2020Laura D'Erasmo, Alessia Di Costanzo, Marcello Arca
Current Atherosclerosis Reports|August 28, 2020
Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and TreatmentAntonio Gallo, Sophie Béliard, Laura D'Erasmo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 15, 2022
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemiaDominique Larrey, Laura D'Erasmo, Sallyann O'Brien, et al.
Current Opinion in Lipidology|October 7, 2022
Recent Apolipoprotein CIII trialsDaniele Tramontano, Simone Bini, Laura D'Erasmo, et al.
Internal and Emergency Medicine|May 18, 2026
Targeting triglycerides for cardiovascular risk reductionCarlo Maiorca, Daniele Tramontano, Alessia Di Costanzo, et al.
Endocrinology and Metabolism Clinics of North America|August 13, 2022
New and Emerging Therapies for DyslipidemiaAlberto Zambon, Maurizio Averna, Laura D'Erasmo, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Frontiers in Cardiovascular Medicine|June 13, 2025
Editorial: Cardiovascular risk and lipoprotein(a): beyond LDL cholesterolGiuseppe Mandraffino, Laura D'Erasmo
Current Opinion in Lipidology|February 6, 2020
Familial combined hypolipidemia: angiopoietin-like protein-3 deficiencyMarcello Arca, Laura D'Erasmo, Ilenia Minicocci
Current Atherosclerosis Reports|September 1, 2021
Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)Laura D'Erasmo, Simone Bini, Marcello Arca
Current Opinion in Endocrinology, Diabetes, and Obesity|November 10, 2025
Lessons from recent clinical trials for the prevention of acute pancreatitis in chylomicronemia syndromesLaura D'Erasmo, Daniele Tramontano, Marcello Arca
Current Opinion in Lipidology|February 4, 2020
Autosomal recessive hypercholesterolemia: update for 2020Laura D'Erasmo, Alessia Di Costanzo, Marcello Arca
Current Atherosclerosis Reports|August 28, 2020
Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and TreatmentAntonio Gallo, Sophie Béliard, Laura D'Erasmo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 15, 2022
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemiaDominique Larrey, Laura D'Erasmo, Sallyann O'Brien, et al.
Current Opinion in Lipidology|October 7, 2022
Recent Apolipoprotein CIII trialsDaniele Tramontano, Simone Bini, Laura D'Erasmo, et al.
Internal and Emergency Medicine|May 18, 2026
Targeting triglycerides for cardiovascular risk reductionCarlo Maiorca, Daniele Tramontano, Alessia Di Costanzo, et al.
Endocrinology and Metabolism Clinics of North America|August 13, 2022
New and Emerging Therapies for DyslipidemiaAlberto Zambon, Maurizio Averna, Laura D'Erasmo, et al.
Pageof 8